Literature DB >> 82532

Effects of proteolytic enzymes and neuraminidase on the I and i erythrocyte antigen sites. Quantitative and thermodynamic studies.

C Doînel, C Ropars, C Salmon.   

Abstract

The effects of neuraminidase and proteolytic enzymes on I and i reactivities was studied with I and i adult red cells, using radioimmunological methods. An enhanced reactivity after enzyme treatment is not exclusively due to a membrane charge reduction. The increase in site numbers and association constants bring about the gain of the cold agglutinin fixation. The release of N-acetylneuraminic acid residues gradually increases the I antigen site density of I red cells and the i site density of i red cells. Similar behaviour was observed after proteolytic enzyme treatment with papain, bromelin or ficin. The proteolytic treatment of I erythrocyte reveals underlying i receptors on these cells. Following membrane glycoprotein chain removal, anti-i antibodies are specifically fixed on I erythrocytes. The accessibility to antibodies of the determinants responsible for I and i erythrocyte activities was influenced significantly by steric hindrance factors. While N-acetylneuraminic acid release increased antibody affinities for the antigenic receptor, the removal of glycopeptide chains greatly diminished steric hindrance and brought about higher affinity constants. After enzyme treatment, the antigenic structures become more homogeneous in their reaction with antibodies. The heterogeneity of binding constants observed with antigenic determinants of non-treated erythrocytes is probably due to the wide range of spatial distribution of these receptors within the membrane.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82532      PMCID: PMC1457185     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Studies on glycopeptides released by trypsin from intact human erythrocytes.

Authors:  R J Winzler; E D Harris; D J Pekas; C A Johnson; P Weber
Journal:  Biochemistry       Date:  1967-07       Impact factor: 3.162

2.  The simultaneous presence of anti-I and anti-i in sera.

Authors:  V A Jackson; P D Issitt; B J Francis; M L Garris; C W Sanders
Journal:  Vox Sang       Date:  1968       Impact factor: 2.144

3.  Use of azo-dye-bound collagen to measure reaction velocities of proteolytic enzymes.

Authors:  G L Moore
Journal:  Anal Biochem       Date:  1969-10-15       Impact factor: 3.365

4.  N-acetylneuraminic (sialic) acid and human blood group antigen structure.

Authors:  G W Bird; J Wingham
Journal:  Vox Sang       Date:  1970-03       Impact factor: 2.144

5.  Reaction of cold agglutinins with I antigen solubilized from human red cells.

Authors:  W F Rosse; P K Lauf
Journal:  Blood       Date:  1970-12       Impact factor: 22.113

6.  A new serological specificity in cold antibodies of high titre: anti-HD.

Authors:  D Roelcke
Journal:  Vox Sang       Date:  1969-01       Impact factor: 2.144

7.  Quantitative and thermodynamic measurements on I and i antigens of human red blood cells.

Authors:  C Doinel; C Ropars; C Salmon
Journal:  Immunology       Date:  1976-02       Impact factor: 7.397

8.  I-, MN- and Pr1/Pr2-activity of human erythrocyte glycoprotein fractions obtained by ficin treatment.

Authors:  D Roelcke; W Ebert; J Metz; H Weicker
Journal:  Vox Sang       Date:  1971-10       Impact factor: 2.144

9.  MN blood-group active sialoglycopeptides released from human erythrocytes by pronase treatment.

Authors:  S Ohkuma; T Shinohara
Journal:  Biochim Biophys Acta       Date:  1967-09-19

10.  Heterogeneity of cold haemagglutinins.

Authors:  O Tönder; M Harboe
Journal:  Immunology       Date:  1966-10       Impact factor: 7.397

View more
  1 in total

1.  Production of a recombinant antibody specific for i blood group antigen, a mesenchymal stem cell marker.

Authors:  Tia Hirvonen; Heli Suila; Sari Tiitinen; Suvi Natunen; Marja-Leena Laukkanen; Annika Kotovuori; Mirka Reinman; Tero Satomaa; Kaija Alfthan; Saara Laitinen; Kristiina Takkinen; Jarkko Räbinä; Leena Valmu
Journal:  Biores Open Access       Date:  2013-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.